Strata Critical Medical, Inc.
SRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $329 | $260 | $255 | $729 |
| - Cash | $18 | $28 | $43 | $3 |
| + Debt | $9 | $25 | $18 | $1 |
| Enterprise Value | $320 | $256 | $230 | $727 |
| Revenue | $249 | $225 | $146 | $51 |
| % Growth | 10.4% | 54.1% | 189.2% | – |
| Gross Profit | $59 | $42 | $22 | $11 |
| % Margin | 23.7% | 18.7% | 15.2% | 20.8% |
| EBITDA | -$28 | -$61 | -$70 | -$23 |
| % Margin | -11.2% | -27.1% | -47.8% | -46.5% |
| Net Income | -$27 | -$56 | -$27 | -$40 |
| % Margin | -11% | -24.9% | -18.7% | -79.3% |
| EPS Diluted | -0.35 | -0.76 | -0.38 | -0.57 |
| % Growth | 53.9% | -100% | 33.3% | – |
| Operating Cash Flow | -$3 | -$32 | -$37 | -$16 |
| Capital Expenditures | -$33 | -$2 | -$1 | -$1 |
| Free Cash Flow | -$36 | -$34 | -$38 | -$16 |